FDA Voucher Leads to Speedy Approval of Boehringer Drug for First-Line Use in Lung Cancer
The label growth for Boehringer Ingelheim’s Hernexeos was made beneath an FDA pilot program that accelerates regulatory assessment of merchandise ...
Tag: Boehringer
Boehringer Boosts Pipeline, Adding Oral Small Molecules With Broad Immunology & Inflammation Potential
Boehringer Ingelheim receives rights to oral small molecules from Sitryx with potential purposes in a number of autoimmune issues. Relying ...
Bayer Lung Cancer Drug Lands Speedy FDA Nod to Stay Competitive With a Boehringer Ingelheim Med
A Bayer drug designed to target tumors driven by a rare genetic mutation now has accelerated FDA approval, providing another ...
Datavant, Boehringer Ingelheim partner to enhance clinical development
Data sharing technology company Datavant has expanded its collaboration with pharmaceutical company Boehringer Ingelheim to support Boehringer's real-world evidence initiatives. ...
GoodRx, Boehringer Ingelheim Launch Initiative for Humira Biosimilar
Drugmaker Boehringer Ingelheim and prescription savings platform GoodRx have teamed up to provide Boehringer’s Humira biosimilar for an exclusive cash ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!